Pratensein

Pyridine, 2-chloro-6-(4-piperidinylthio)-, hydrochloride (1:1) (ACI)

Immunoglobulin, anti-(human cytotoxic T-lymphocyte-associated protein 4) (human-Mus musculus monoclonal XmAb20717 single-chain variable fragment VL-linker-VH) fusion protein with immunoglobulin G1 (human γ1-chain C-region C-terminal fragment), (260→227′),(263→230′)-bis(disulfide) with immunoglobulin G1 anti-(human programmed cell death 1) (human-Mus musculus monoclonal XmAb20717 γ1-chain) disulfide with human-Mus musculus monoclonal XmAb20717 κ-chain (ACI)

Efalizumab

DNA d(P-thio)([2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]rG-G-T-T-A-m5C-A-T-G-A-A-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]m5rC) (ACI)

Myristyl myristate

Ethyl 9H-xanthene-9-carboxylate (ACI)

Immunoglobulin G1 [de-450-lysine], anti-(human sodium-dependent phosphate transport protein 2B) (human-Mus musculus monoclonal XMT-1535 γ1-chain), disulfide with human-Mus musculus monoclonal XMT-1535 κ-chain, dimer (ACI)